Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, discusses the future of the field.
Source: MedTech Dive
You may also like
Facing Funding Losses, States Call Out Big Businesses...
SS Innovations names Sarah Romano as CFO
Judge tosses another No Surprises lawsuit against...
Doctor pay to drop in 2027 under proposed Medicare pay...
Elevance shuts down D.C. Medicaid business, eyes...
Providence names new chief supply chain officer
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.